{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:23:43Z","timestamp":1794489823667,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41585-025-01106-7","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:50:10Z","timestamp":1762523410000},"page":"374-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Atypical intraductal proliferation in prostate biopsy \u2014 a diagnostic grey zone with clinical implications"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-4550","authenticated-orcid":false,"given":"Rui M.","family":"Bernardino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-1391","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7127-6069","authenticated-orcid":false,"given":"Jihad","family":"Kaouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-5786","authenticated-orcid":false,"given":"Theodorus","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Prendeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-373X","authenticated-orcid":false,"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-1536","authenticated-orcid":false,"given":"Lorenzo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-7154","authenticated-orcid":false,"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4073-6584","authenticated-orcid":false,"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0832-382X","authenticated-orcid":false,"given":"Veeru","family":"Kasivisvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Young Academic Urologists Working Group Prostate Cancer Board","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Heidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeru","family":"Kasivisvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Preisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Rodriguez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Soeterik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Falagario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Fasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Giesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Hogehout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Le Guevelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mercinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Puche Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Roesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Scheltema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August","family":"Sigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Stroomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1106_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","volume":"20","author":"JE McNeal","year":"1996","unstructured":"McNeal, J. E. & Yemoto, C. E. M. Spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations. Am. J. Surg. Pathol. 20, 802\u2013814 (1996).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/iju.12657","volume":"22","author":"T Tsuzuki","year":"2015","unstructured":"Tsuzuki, T. Intraductal carcinoma of the prostate: a comprehensive and updated review. Int. J. Urol. 22, 140\u2013145 (2015).","journal-title":"Int. J. Urol."},{"key":"1106_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","volume":"45","author":"TH Van Der Kwast","year":"2021","unstructured":"Van Der Kwast, T. H. et al. ISUP consensus definition of cribriform pattern prostate cancer. Am. J. Surg. Pathol. 45, 1118\u20131126 (2021).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR4","doi-asserted-by":"publisher","first-page":"151733","DOI":"10.1016\/j.anndiagpath.2021.151733","volume":"52","author":"KA Iczkowski","year":"2021","unstructured":"Iczkowski, K. A. et al. Cribriform prostate cancer: morphologic criteria enabling a diagnosis, based on survey of experts. Ann. Diagn. Pathol. 52, 151733 (2021).","journal-title":"Ann. Diagn. Pathol."},{"key":"1106_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.5858\/2007-131-1103-APOTIH","volume":"131","author":"RJ Cohen","year":"2007","unstructured":"Cohen, R. J., Wheeler, T. M., Bonkhoff, H. & Rubin, M. A. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. Arch. Pathol. Lab. Med. 131, 1103\u20131109 (2007).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1106_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/path.4628","volume":"238","author":"MC Haffner","year":"2016","unstructured":"Haffner, M. C. et al. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. J. Pathol. 238, 31\u201341 (2016).","journal-title":"J. Pathol."},{"key":"1106_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","volume":"21","author":"KA Moses","year":"2023","unstructured":"Moses, K. A. et al. NCCN Guidelines\u00ae insights: prostate cancer early detection, version 1.2023: featured updates to the NCCN guidelines. J. Natl Compr. Canc. Netw. 21, 236\u2013246 (2023).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"1106_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0022-5347(05)00337-X","volume":"175","author":"JI Epstein","year":"2006","unstructured":"Epstein, J. I. & Herawi, M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J. Urol. 175, 820\u2013834 (2006).","journal-title":"J. Urol."},{"key":"1106_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/his.13273","volume":"71","author":"RB Shah","year":"2017","unstructured":"Shah, R. B., Yoon, J., Liu, G. & Tian, W. Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma. Histopathology 71, 693\u2013702 (2017).","journal-title":"Histopathology"},{"key":"1106_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.eururo.2005.03.015","volume":"48","author":"S Joniau","year":"2005","unstructured":"Joniau, S., Goeman, L., Pennings, J. & Van Poppel, H. Prostatic intraepithelial neoplasia (PIN): importance and clinical management. Eur. Urol. 48, 379\u2013385 (2005).","journal-title":"Eur. Urol."},{"key":"1106_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.urology.2017.04.021","volume":"107","author":"TG Manning","year":"2017","unstructured":"Manning, T. G. et al. Atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in the era of multiparametric magnetic resonance imaging: a contemporary review. Urology 107, 5\u201310 (2017).","journal-title":"Urology"},{"key":"1106_CR12","doi-asserted-by":"publisher","unstructured":"Aldaoud, N. et al. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia in a tertiary hospital in Northern Jordan. Clin. Pathol. https:\/\/doi.org\/10.1177\/2632010X19898472 (2020).","DOI":"10.1177\/2632010X19898472"},{"key":"1106_CR13","doi-asserted-by":"publisher","first-page":"120.e1","DOI":"10.1016\/j.urolonc.2015.10.008","volume":"34","author":"RB Shah","year":"2016","unstructured":"Shah, R. B., Li, J., Dhanani, N. & Mendrinos, S. ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia. Urol. Oncol. 34, 120.e1\u2013120.e7 (2016).","journal-title":"Urol. Oncol."},{"key":"1106_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002430","author":"KA Iczkowski","year":"2025","unstructured":"Iczkowski, K. A. et al. International Society of Urological Pathology consensus on cancer precursor lesions. Working Group 1: the prostate. Am. J. Surg. Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000002430 (2025).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR15","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/modpathol.3800702","volume":"19","author":"CC Guo","year":"2006","unstructured":"Guo, C. C. & Epstein, J. I. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod. Pathol. 19, 1528\u20131535 (2006).","journal-title":"Mod. Pathol."},{"key":"1106_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.humpath.2014.03.011","volume":"45","author":"K Miyai","year":"2014","unstructured":"Miyai, K. et al. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion. Hum. Pathol. 45, 1572\u20131581 (2014).","journal-title":"Hum. Pathol."},{"key":"1106_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/PAP.0b013e31825c6c0e","volume":"19","author":"RB Shah","year":"2012","unstructured":"Shah, R. B. & Zhou, M. Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate. Adv. Anat. Pathol. 19, 270\u2013278 (2012).","journal-title":"Adv. Anat. Pathol."},{"key":"1106_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/PAS.0b013e3181cfc44b","volume":"34","author":"RB Shah","year":"2010","unstructured":"Shah, R. B., Magi-Galluzzi, C., Han, B. & Zhou, M. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies. Am. J. Surg. Pathol. 34, 470\u2013477 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/JU.0000000000003850","volume":"211","author":"R Bernardino","year":"2024","unstructured":"Bernardino, R. et al. Intraductal prostate cancer affinity for lymphatic-predominant metastases through 18F-DCFPyL\u2012prostate-specific membrane antigen\u2012positron emission tomography\/CT scans in pretreatment prostate cancer patients. J. Urol. 211, 586\u2013593 (2024).","journal-title":"J. Urol."},{"key":"1106_CR20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.euf.2023.05.005","volume":"9","author":"R Bernardino","year":"2023","unstructured":"Bernardino, R. et al. Lymphotropic pattern of prostate-specific membrane antigen-detected metastases among biochemically recurrent radical prostatectomy patients with cribriform disease. Eur. Urol. Focus\u00a09, 1016\u20131023 (2023).","journal-title":"Eur. Urol. Focus"},{"key":"1106_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.urology.2017.03.030","volume":"105","author":"BF Dinerman","year":"2017","unstructured":"Dinerman, B. F., Bernstein, A. N., Khani, F. & Hu, J. C. Intraductal carcinoma of the prostate: a risk for rapid recurrence. Urology 105, e1\u2013e2 (2017).","journal-title":"Urology"},{"key":"1106_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/14737140.2018.1469406","volume":"18","author":"R Montironi","year":"2018","unstructured":"Montironi, R. et al. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma. Expert. Rev. Anticancer Ther. 18, 685\u2013693 (2018).","journal-title":"Expert. Rev. Anticancer Ther."},{"key":"1106_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/modpathol.2014.116","volume":"28","author":"CF Kweldam","year":"2015","unstructured":"Kweldam, C. F. et al. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Mod. Pathol. 28, 457\u2013464 (2015).","journal-title":"Mod. Pathol."},{"key":"1106_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3976-z","volume":"18","author":"R B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, R. et al. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations. BMC Cancer 18, 8 (2018).","journal-title":"BMC Cancer"},{"key":"1106_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ejca.2012.02.003","volume":"48","author":"T Van Der Kwast","year":"2012","unstructured":"Van Der Kwast, T. et al. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. Eur. J. Cancer 48, 1318\u20131325 (2012).","journal-title":"Eur. J. Cancer"},{"key":"1106_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/pros.22579","volume":"73","author":"H Bonkhoff","year":"2013","unstructured":"Bonkhoff, H. et al. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer? Prostate 73, 442\u2013448 (2013).","journal-title":"Prostate"},{"key":"1106_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","volume":"136","author":"KA Iczkowski","year":"2011","unstructured":"Iczkowski, K. A. et al. Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome. Am. J. Clin. Pathol. 136, 98\u2013107 (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"1106_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/PAS.0b013e3181d6827b","volume":"34","author":"B Han","year":"2010","unstructured":"Han, B. et al. ETS gene aberrations in atypical cribriform lesions of the prostate: implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia. Am. J. Surg. Pathol. 34, 478\u2013485 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/PAS.0000000000000794","volume":"41","author":"RA Hickman","year":"2017","unstructured":"Hickman, R. A. et al. Atypical intraductal cribriform proliferations of the prostate exhibit similar molecular and clinicopathologic characteristics as intraductal carcinoma of the prostate. Am. J. Surg. Pathol. 41, 550\u2013556 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/PAS.0000000000002376","volume":"49","author":"R Bhattarai","year":"2025","unstructured":"Bhattarai, R. et al. Atypical intraductal proliferation in prostate needle core biopsy: validation as a marker of unsampled adverse pathology in a clinicopathologic series of 142 new patients. Am. J. Surg. Pathol. 49, 515\u2013522 (2025).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/his.13878","volume":"75","author":"RB Shah","year":"2019","unstructured":"Shah, R. B. et al. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes. Histopathology 75, 346\u2013353 (2019).","journal-title":"Histopathology"},{"key":"1106_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","volume":"145","author":"JI Epstein","year":"2021","unstructured":"Epstein, J. I. et al. The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer. Arch. Pathol. Lab. Med. 145, 461\u2013493 (2021).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1106_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey, P. A., Moch, H., Cubilla, A. L., Ulbright, T. M. & Reuter, V. E. The 2016 WHO classification of tumours of the urinary system and male genital organs \u2014 Part B: prostate and bladder tumours. Eur. Urol. 70, 106\u2013119 (2016).","journal-title":"Eur. Urol."},{"key":"1106_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.euf.2023.08.010","volume":"10","author":"RM Bernardino","year":"2023","unstructured":"Bernardino, R. M. et al. Limitations of prostate biopsy in detection of cribriform and intraductal prostate cancer. Eur. Urol. Focus 10, 146\u2013153 (2023).","journal-title":"Eur. Urol. Focus"},{"key":"1106_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41391-024-00910-3","volume":"28","author":"RM Bernardino","year":"2024","unstructured":"Bernardino, R. M. et al. Undetected cribriform and intraductal prostate cancer at biopsy is associated with adverse outcomes. Prostate Cancer Prostatic Dis. 28, 187\u2013192 (2024).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1106_CR36","doi-asserted-by":"publisher","first-page":"452.e1","DOI":"10.1016\/j.urolonc.2022.07.012","volume":"40","author":"Q Cai","year":"2022","unstructured":"Cai, Q. et al. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (cribriform Gleason pattern 4 and intraductal carcinoma): correlation of detected and missed prostate cancer foci with whole mount histopathology. Urol. Oncol. 40, 452.e1\u2013452.e8 (2022).","journal-title":"Urol. Oncol."},{"key":"1106_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/PAP.0000000000000303","volume":"28","author":"M Varma","year":"2021","unstructured":"Varma, M. Intraductal carcinoma of the prostate: a guide for the practicing pathologist. Adv. Anat. Pathol. 28, 276\u2013287 (2021).","journal-title":"Adv. Anat. Pathol."},{"key":"1106_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.anndiagpath.2014.08.010","volume":"18","author":"KA Iczkowski","year":"2014","unstructured":"Iczkowski, K. A. et al. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Ann. Diagn. Pathol. 18, 333\u2013342 (2014).","journal-title":"Ann. Diagn. Pathol."},{"key":"1106_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/his.13081","volume":"70","author":"M Varma","year":"2017","unstructured":"Varma, M., Egevad, L., Delahunt, B. & Kristiansen, G. Reporting intraductal carcinoma of the prostate: a plea for greater standardization. Histopathology 70, 504\u2013507 (2017).","journal-title":"Histopathology"},{"key":"1106_CR40","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jclinpath-2016-203658","volume":"69","author":"M Varma","year":"2016","unstructured":"Varma, M. et al. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists. J. Clin. Pathol. 69, 852\u2013857 (2016).","journal-title":"J. Clin. Pathol."},{"key":"1106_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/JU.0000000000003775","volume":"211","author":"MS Sessine","year":"2024","unstructured":"Sessine, M. S. et al. Can MRI help inform which men with a history of multifocal high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation remain at an elevated risk for clinically significant prostate cancer? J. Urol. 211, 234\u2013240 (2024).","journal-title":"J. Urol."},{"key":"1106_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000447181","volume":"10","author":"V Srirangam","year":"2017","unstructured":"Srirangam, V. et al. Atypical small acinar proliferation and high grade prostatic intraepithelial neoplasia: should we be concerned? an observational cohort study with a minimum follow-up of 3 years. Curr. Urol. 10, 199\u2013205 (2017).","journal-title":"Curr. Urol."},{"key":"1106_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-11603-3","author":"F Carletti","year":"2025","unstructured":"Carletti, F. et al. Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysis. Eur. Radiol. https:\/\/doi.org\/10.1007\/s00330-025-11603-3 (2025).","journal-title":"Eur. Radiol."},{"key":"1106_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Cancer cell article integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"1106_CR45","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215\u20131228 (2015).","journal-title":"Cell"},{"key":"1106_CR46","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/modpathol.2012.104","volume":"25","author":"A Chaux","year":"2012","unstructured":"Chaux, A. et al. Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer. Mod. Pathol. 25, 1543\u20131549 (2012).","journal-title":"Mod. Pathol."},{"key":"1106_CR47","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.bjc.6603924","volume":"97","author":"M Yoshimoto","year":"2007","unstructured":"Yoshimoto, M. et al. FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. Br. J. Cancer 97, 678\u2013685 (2007).","journal-title":"Br. J. Cancer"},{"key":"1106_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","volume":"19","author":"BS Carver","year":"2011","unstructured":"Carver, B. S. et al. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19, 575\u2013586 (2011).","journal-title":"Cancer Cell"},{"key":"1106_CR49","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.euo.2024.06.008","volume":"7","author":"E Lee","year":"2024","unstructured":"Lee, E. et al. PTEN loss is associated with adverse outcomes in the setting of salvage radiation therapy. Eur. Urol. Oncol. 7, 1513\u20131519 (2024).","journal-title":"Eur. Urol. Oncol."},{"key":"1106_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","volume":"76","author":"AA Hamid","year":"2019","unstructured":"Hamid, A. A. et al. Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer. Eur. Urol. 76, 89\u201397 (2019).","journal-title":"Eur. Urol."},{"key":"1106_CR51","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1200\/JCO.2011.35.1916","volume":"29","author":"MA Rubin","year":"2011","unstructured":"Rubin, M. A., Maher, C. A. & Chinnaiyan, A. M. Common gene rearrangements in prostate cancer. J. Clin. Oncol. 29, 3659 (2011).","journal-title":"J. Clin. Oncol."},{"key":"1106_CR52","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/modpathol.2013.248","volume":"27","author":"TM Schneider","year":"2014","unstructured":"Schneider, T. M. & Osunkoya, A. O. ERG expression in intraductal carcinoma of the prostate: comparison with adjacent invasive prostatic adenocarcinoma. Mod. Pathol. 27, 1174\u20131178 (2014).","journal-title":"Mod. Pathol."},{"key":"1106_CR53","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00428-023-03643-1","volume":"485","author":"C Martini","year":"2024","unstructured":"Martini, C. et al. Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Arch. Int. J. Pathol. 485, 723\u2013728 (2024).","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"1106_CR54","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.pathol.2023.05.004","volume":"55","author":"A Sorvina","year":"2023","unstructured":"Sorvina, A. et al. Appl1, sortilin and syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread. Pathology 55, 792\u2013799 (2023).","journal-title":"Pathology"},{"key":"1106_CR55","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.modpat.2023.100130","volume":"36","author":"E Vormittag-Nocito","year":"2023","unstructured":"Vormittag-Nocito, E. et al. In-depth comparison of genetic variants demonstrates a close relationship between invasive and intraductal components of prostate cancer. Mod. Pathol. 36, 100130 (2023).","journal-title":"Mod. Pathol."},{"key":"1106_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.5283","volume":"249","author":"F Khani","year":"2019","unstructured":"Khani, F. et al. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations. J. Pathol. 249, 79\u201389 (2019).","journal-title":"J. Pathol."},{"key":"1106_CR57","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/his.15414","volume":"86","author":"LL Rijstenberg","year":"2025","unstructured":"Rijstenberg, L. L. et al. Identification of intraductal-to-invasive spatial transitions in prostate cancer: proposal for a new unifying model on intraductal carcinogenesis. Histopathology 86, 1091\u20131100 (2025).","journal-title":"Histopathology"},{"key":"1106_CR58","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/pin.13369","volume":"73","author":"T Ito","year":"2023","unstructured":"Ito, T. et al. PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patients. Pathol. Int. 73, 542\u2013548 (2023).","journal-title":"Pathol. Int."},{"key":"1106_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13671","volume":"8","author":"RA Taylor","year":"2017","unstructured":"Taylor, R. A. et al. Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories. Nat. Commun. 8, 13671 (2017).","journal-title":"Nat. Commun."},{"key":"1106_CR60","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/modpathol.2012.201","volume":"26","author":"TL Lotan","year":"2013","unstructured":"Lotan, T. L. et al. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia. Mod. Pathol. 26, 587\u2013603 (2013).","journal-title":"Mod. Pathol."},{"key":"1106_CR61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/gcc.20560","volume":"47","author":"O Bettendorf","year":"2008","unstructured":"Bettendorf, O. et al. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate. Genes Chromosomes Cancer 47, 565\u2013572 (2008).","journal-title":"Genes Chromosomes Cancer"},{"key":"1106_CR62","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/0046-8177(91)90286-X","volume":"22","author":"JE McNeal","year":"1991","unstructured":"McNeal, J. E., Villers, A., Redwine, E. A., Freiha, F. S. & Stamey, T. A. Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum. Pathol. 22, 644\u2013652 (1991).","journal-title":"Hum. Pathol."},{"key":"1106_CR63","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/00000478-200209000-00005","volume":"26","author":"BR Oliai","year":"2002","unstructured":"Oliai, B. R., Kahane, H. & Epstein, J. I. Can basal cells be seen in adenocarcinoma of the prostate? An immunohistochemical study using high molecular weight cytokeratin (clone 34\u03b2E12) antibody. Am. J. Surg. Pathol. 26, 1151\u20131160 (2002).","journal-title":"Am. J. Surg. Pathol."},{"key":"1106_CR64","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/his.12928","volume":"69","author":"M Varma","year":"2016","unstructured":"Varma, M., Alchami, F. S. & Griffiths, D. F. R. Retained basal cells in metastatic prostate cancer. Histopathology 69, 338\u2013340 (2016).","journal-title":"Histopathology"}],"updated-by":[{"DOI":"10.1038\/s41585-025-01114-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000}}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01106-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:02:11Z","timestamp":1780920131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01106-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-01106-7","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"9 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41585-025-01114-7","URL":"https:\/\/doi.org\/10.1038\/s41585-025-01114-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}